- Home
- PULM vs JFU Comparison
PULM vs JFU Comparison
Compare PULM & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- JFU
- Stock Information
- Founded
- PULM 2003
- JFU 2006
- Country
- PULM United States
- JFU China
- Employees
- PULM N/A
- JFU N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- JFU Finance: Consumer Services
- Sector
- PULM Health Care
- JFU Finance
- Exchange
- PULM Nasdaq
- JFU Nasdaq
- Market Cap
- PULM 18.3M
- JFU 17.1M
- IPO Year
- PULM N/A
- JFU 2019
- Fundamental
- Price
- PULM N/A
- JFU N/A
- Analyst Decision
- PULM
- JFU
- Analyst Count
- PULM 0
- JFU 0
- Target Price
- PULM N/A
- JFU N/A
- AVG Volume (30 Days)
- PULM 17.8K
- JFU 6.0K
- Earning Date
- PULM 11-07-2025
- JFU 12-09-2022
- Dividend Yield
- PULM N/A
- JFU N/A
- EPS Growth
- PULM N/A
- JFU 3110.57
- EPS
- PULM N/A
- JFU 3.04
- Revenue
- PULM $369,000.00
- JFU $44,573,690.00
- Revenue This Year
- PULM N/A
- JFU N/A
- Revenue Next Year
- PULM $134.88
- JFU N/A
- P/E Ratio
- PULM N/A
- JFU $0.89
- Revenue Growth
- PULM N/A
- JFU 8.19
- 52 Week Low
- PULM $1.96
- JFU $1.01
- 52 Week High
- PULM $10.40
- JFU $3.25
- Technical
- Relative Strength Index (RSI)
- PULM 47.11
- JFU 67.49
- Support Level
- PULM $4.45
- JFU $2.58
- Resistance Level
- PULM $5.50
- JFU $2.83
- Average True Range (ATR)
- PULM 0.26
- JFU 0.13
- MACD
- PULM 0.02
- JFU -0.01
- Stochastic Oscillator
- PULM 38.53
- JFU 84.60
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About JFU 9F Inc.
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company generates the majority of its revenue from Loan facilitation services. All its revenues are generated from the People's Republic of China.